National Cannabis Review

Linking the Marijuana Industry
Industry Links
Medical Links

District of Columbia Special Events (2)

National Cannabis Industry Associations NCIA upcoming Policy Symposium and Member Lobby Days
Join the National Cannabis Industry Association to discuss the federal policy outlook and lobby on Capitol Hill for cannabis reform.
Located on Capitol Hill, the 20 F Street NW Conference Center is a new meeting and conference facility located within walking distance of the Un...

National Cannabis Industry Associations NCIA upcoming Policy Symposium and Member Lobby Days

Cannabis Policy and Reform Symposium
Washington DC
Without a strong political machine driving legal reforms across the country, there would be no cannabis industry. This one day conference focuses on the latest efforts to reform state and federal marijuana laws. The event will be held along side NCIAs lobby days, and will feature...
Add a listing

National Cannabis Industry News    Search Industry News: 
The Joint Blog | December 27, 2018
 Oregon Approves Medical Marijuana Deliveries, Increases Purchase Limits

Anthony Martinelli

The Oregon Liquor Control Commission has approved several changes to the states medical marijuana program.
The commission, which oversees Oregons medical marijuana law, has given approval to a change in the states law that allows the medicine to be delivered to patients or their caregiver. The commission also passed an increase in the amount of medical marijuana a patient can purchase to eight ounces in a single day and up to 32 ounces in a single month. In addition, the commission voted to allow wholesale license holders to provide retailers with samples. The change in law allowing medical marijuana to be delivered unfortunately doesnt apply to recreational marijuana. Oregon....
View more in new window
NORML | December 21, 2018
 FDA Weighs In On Legal Status of Commercially Available Hemp-Derived CBD Products

Following yesterdays passage of the 2018 Farm Bill, US Food and Drug Administration Commissioner Scott Gottleib issued a statement with regard to the agencys oversight of products commercially marketed as hemp-derived CBD. The FDA states: Were aware of the growing public interest in cannabis and cannabis-derived products, including cannabidiol CBD. This increasing public interest in these products makes it even more important with the passage of this law for the FDA to clarify its regulatory authority over these products. In short, we treat products containing cannabis or ....
View more in new window
NORML | December 7, 2018
 A NORML Statement on William Barr as Attorney General Nominee

Washington, DC: Today, President Trump announced his intention to nominate former Attorney General William Barr to be considered by the Senate to replace former Attorney General Jefferson Beauregard Sessions. With every move by the Department of Justice facing intense public scrutiny, maintaining Jeff Sessions policy of reefer madness would be self-defeating, said NORML Political Director Justin Strekal. The movement to end the failed and cruel policy of marijuana criminalization is larger and stronger than ever, supported by a majority of Democrats, Republicans, and non-p....
View more in new window

Older cannabis industry news.
Mission Statement
Privacy Statement
Rating System
Link Back
Contact Mark
© Copyright 2017-2017
We make every effort to provide timely and accurate information, however we cannot guaranty the accuracy of these listings.
To correct a listing, please use the corrections link or contact the web master, Mark.
This web site contains no advertising. Listings in this directory are licensed business.
Reviews and editorials are the opinion of the author only, not those of the National Cannabis Review.
No Sign In -- Minimum Digital Footprint
Reduce violence on the border, support local growers, keep your cash in your community, and get consistent quality Legalize It World Wide!.